IP Library Granted Patent US 8,470,582
Granted Patent B2
US 8,470,582 · App. 13/065,303 · Granted Jun 25, 2013

Methods and organisms for the growth-coupled production of 1,4-butanediol

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,470,582
App. No.
13/065,303
Granted
Jun 25, 2013
Kind
B2
Abstract

The invention provides a non-naturally occurring microorganism comprising one or more gene disruptions, the one or more gene disruptions occurring in genes encoding an enzyme obligatory to coupling 1,4-butanediol production to growth of the microorganism when the gene disruption reduces an activity of the enzyme, whereby the one or more gene disruptions confers stable growth-coupled production of 1,4-butanediol onto the non-naturally occurring microorganism. The microorganism can further comprise a gene encoding an enzyme in a 1,4-butanediol (BDO) biosynthetic pathway. The invention additionally relates to methods of using microorganisms to produce BDO.

Claims (8)

1. A non-naturally occurring Escherichia coli microorganism comprising a set of metabolic modifications, said set of metabolic modifications comprising disruption of genes encoding alcohol dehydrogenase, malate dehydrogenase, aspartate transaminase, lactate dehydrogenase and succinyl-CoA synthetase, wherein said microorganism expresses heterologous enzymes that provide production of 1,4-butanediol.

2. The non-naturally occurring microorganism of claim 1 , wherein one or more of said gene disruptions comprise a deletion of one or more of said genes.

3. The non-naturally occurring microorganism of claim 2 , wherein each of said gene disruptions comprise a deletion.

4. A method of producing 1,4-butanediol, comprising:

(a) culturing the non-naturally occurring microorganism of claim 1 ; and

(b) isolating 1,4-butanediol produced from said non-naturally occurring microorganism.

5. The method of claim 4 , wherein one or more of said gene disruptions comprise a deletion of one or more of said genes.

6. The method of claim 5 , wherein each of said gene disruptions comprise a deletion.

Assignments (3)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →